Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 4985323, 13 pages
Research Article

Overexpression of Heme Oxygenase-1 in Mesenchymal Stem Cells Augments Their Protection on Retinal Cells In Vitro and Attenuates Retinal Ischemia/Reperfusion Injury In Vivo against Oxidative Stress

1Department of Ophthalmology, Jinan Military General Hospital, No. 25 Shifan Road, Tianqiao District, Jinan 250031, China
2Department of Ophthalmology, The 88th Hospital of Chinese People’s Liberation Army, No. 6 Hushan East Road, Tai’an 271000, China
3Department of Ophthalmology, 401 Hospital of Chinese People’s Liberation Army, No. 22 Minjiang Road, Qingdao 266071, China
4Department of Ophthalmology, Chinese People’s Liberation Army General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China
5Department of Cardre Ward, The 316th Hospital of Chinese People’s Liberation Army, No. A2 Niangniangfu, Xiangshan Road, Haidian District, Beijing 100093, China
6Department of Ophthalmology & Visual Science, University of Louisville, 301 E. Muhammad Ali Blvd., Louisville, KY 40202, USA

Correspondence should be addressed to Hua Jiang; moc.621@801auhgnaiJ

Received 6 September 2016; Revised 26 November 2016; Accepted 21 December 2016; Published 1 February 2017

Academic Editor: Salvatore Scacco

Copyright © 2017 Li Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Retinal ischemia/reperfusion (I/R) injury, involving several ocular diseases, seriously threatens human ocular health, mainly treated by attenuating I/R-induced oxidative stress. Currently, mesenchymal stem cells (MSCs) could restore I/R-injured retina through paracrine secretion. Additionally, heme oxygenase-1 (HO-1) could ameliorate oxidative stress and thus retinal apoptosis, but the expression of HO-1 in MSC is limited. Here, we hypothesized that overexpression of HO-1 in MSC (MSC-HO-1) may significantly improve their retina-protective potentials. The overexpression of HO-1 in MSC was achieved by lentivirus transduction. Then, MSC or MSC-HO-1 was cocultured with retinal ganglion cells (RGC-5) in H2O2-simulated oxidative condition and their protection on RGC-5 was systemically valuated in vitro. Compared with MSC, MSC-HO-1 significantly attenuated H2O2-induced injury of RGC-5, including decrease in cellular ROS level and apoptosis, activation of antiapoptotic proteins p-Akt and Bcl-2, and blockage of proapoptotic proteins cleaved caspase 3 and Bax. In retinal I/R rats model, compared with control MSC, MSC-HO-1-treated retina significantly retrieved its structural thickness, reduced cell apoptosis, markedly attenuated retinal oxidative stress level, and largely regained the activities of typical antioxidant enzymes, SOD and CAT. Therefore, it could be concluded that overexpression of HO-1 provides a promising strategy to enhance the MSC-based therapy for I/R-related retinal injury.